Terms: = Prostate cancer AND LDH AND Diagnosis
43 results:
1. TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive prostate cancer: A Real-World, Multicenter, Retrospective Analysis.
Pisano C; Turco F; Arnaudo E; Fea E; Vanella P; Ruatta F; Filippi R; Brusa F; Prati V; Vana F; Mennitto A; Cattrini C; Vignani F; Dionisio R; Icardi M; Guglielmini P; Buosi R; Stevani I; Vormola R; Numico G; Depetris I; Comandone A; Gennari A; Airoldi M; Rossi M; Vellani G; Ortega C; Tucci M; Maio MD; Buttigliero C
Clin Genitourin Cancer; 2024 Apr; 22(2):56-67.e16. PubMed ID: 37798164
[TBL] [Abstract] [Full Text] [Related]
2. The diagnostic effectiveness of serum sialic acid predicts both qualitative and quantitative prostate cancer in patients with prostate-specific antigen between 4 and 20 ng/mL.
Sun J; Yan L
Front Endocrinol (Lausanne); 2023; 14():1188944. PubMed ID: 37645415
[TBL] [Abstract] [Full Text] [Related]
3. Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant prostate cancer Patients Undergoing prostate-Specific Membrane Antigen-Directed Radioligand Therapy.
Hartrampf PE; Mihatsch PW; Seitz AK; Solnes LB; Rowe SP; Pomper MG; Kübler H; Bley TA; Buck AK; Werner RA
J Nucl Med; 2023 Aug; 64(8):1272-1278. PubMed ID: 37290794
[TBL] [Abstract] [Full Text] [Related]
4. Flower-like core-shell nanostructures based on natural asphalt coated with Ni-ldh nanosheets as an electrochemical platform for prostate cancer biomarker sensing.
Farokhi S; Roushani M
Mikrochim Acta; 2023 May; 190(5):198. PubMed ID: 37126101
[TBL] [Abstract] [Full Text] [Related]
5. Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy.
Saito S; Sakamoto S; Higuchi K; Sato K; Zhao X; Wakai K; Kanesaka M; Kamada S; Takeuchi N; Sazuka T; Imamura Y; Anzai N; Ichikawa T; Kawakami E
Sci Rep; 2023 Apr; 13(1):6325. PubMed ID: 37072487
[TBL] [Abstract] [Full Text] [Related]
6. [OVERALL SURVIVAL EVALUATION OF prostate cancer PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY BY ESTIMATING FLUCTUANT PATTERNS OF METABOLIC FACTOR SERUM LEVELS].
Shimabukuro T; Ohmi C; Baba C; Shiraishi K
Nihon Hinyokika Gakkai Zasshi; 2022; 113(1):1-11. PubMed ID: 36682805
[TBL] [Abstract] [Full Text] [Related]
7. [Prostatic Lymphoma: a rare cause of urinary retention (a case report)].
Namaoui RY; Benremouga MC; Boutoura S; Rahali MC; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
Pan Afr Med J; 2022; 43():33. PubMed ID: 36505021
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic plasma exchange in gastric signet ring cell carcinoma presenting as microangiopathic hemolytic anemia: A rare case report.
Candar O; Ekinci O; Merter M; Aslan M; Aras I
J Clin Apher; 2022 Dec; 37(6):606-610. PubMed ID: 36125111
[TBL] [Abstract] [Full Text] [Related]
9. Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant prostate cancer.
Zhu S; Ni Y; Wang Z; Zhang X; Zhang Y; Zhao F; Dai J; Wang Z; Zhu X; Chen J; Zhao J; Zeng Y; Chen N; Zeng P; Shen P; Sun G; Zeng H
Oncologist; 2022 Nov; 27(11):e870-e877. PubMed ID: 36067250
[TBL] [Abstract] [Full Text] [Related]
10. Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [
Hartrampf PE; Seitz AK; Weinzierl FX; Serfling SE; Schirbel A; Rowe SP; Kübler H; Buck AK; Werner RA
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4262-4270. PubMed ID: 35650263
[TBL] [Abstract] [Full Text] [Related]
11. Treatment of Metastatic Castration-resistant prostate cancer Patients With Abiraterone Acetate and Prednisone and Corresponding Survival Prognostic Factors.
Jimenez Romero ME; Gallego MC; Navarro Serrato JC; Sanchez Hurtado MA; Santotoribio JD
Anticancer Res; 2021 Aug; 41(8):3955-3968. PubMed ID: 34281859
[TBL] [Abstract] [Full Text] [Related]
12. Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive prostate cancer.
Blas L; Shiota M; Yamada S; Ieiri K; Nagakawa S; Tsukahara S; Matsumoto T; Kashiwagi E; Takeuchi A; Inokuchi J; Shiga KI; Yokomizo A; Eto M
Anticancer Res; 2021 Aug; 41(8):3885-3889. PubMed ID: 34281850
[TBL] [Abstract] [Full Text] [Related]
13. Urate Nephropathy from Tumor Lysis Syndrome in an Undiagnosed Case of prostate cancer.
Javed S
Curr Oncol; 2021 Jan; 28(1):440-444. PubMed ID: 33450897
[TBL] [Abstract] [Full Text] [Related]
14. Tumour markers and their utility in imaging of abdominal and pelvic malignancies.
Lahoud RM; O'Shea A; El-Mouhayyar C; Atre ID; Eurboonyanun K; Harisinghani M
Clin Radiol; 2021 Feb; 76(2):99-107. PubMed ID: 32861463
[TBL] [Abstract] [Full Text] [Related]
15. Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-
van Heijster FHA; Heskamp S; Breukels V; Veltien A; Franssen GM; Jansen KCFJ; Boerman OC; Schalken JA; Scheenen TWJ; Heerschap A
NMR Biomed; 2020 Oct; 33(10):e4362. PubMed ID: 32662543
[TBL] [Abstract] [Full Text] [Related]
16. ARNT-dependent CCR8 reprogrammed ldh isoform expression correlates with poor clinical outcomes of prostate cancer.
Chen G; Cai ZD; Lin ZY; Wang C; Liang YX; Han ZD; He HC; Mo RJ; Lu JM; Pan B; Wu CL; Wang F; Zhong WD
Mol Carcinog; 2020 Aug; 59(8):897-907. PubMed ID: 32319143
[TBL] [Abstract] [Full Text] [Related]
17. Serum Prognostic Factors of Androgen-deprivation Therapy Among Japanese Men With
Kobayashi T; Namitome R; Hirata YU; Shiota M; Imada K; Kashiwagi E; Takeuchi A; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2019 Jun; 39(6):3191-3195. PubMed ID: 31177166
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive prostate cancer.
Miyake H; Matsushita Y; Watanabe H; Tamura K; Motoyama D; Ito T; Sugiyama T; Otsuka A
Anticancer Res; 2019 Mar; 39(3):1391-1396. PubMed ID: 30842173
[TBL] [Abstract] [Full Text] [Related]
19. Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic prostate cancer.
Nieder C; Dalhaug A; Pawinski A
In Vivo; 2019; 33(2):465-468. PubMed ID: 30804126
[TBL] [Abstract] [Full Text] [Related]
20. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
Liu L; He Y; Ge G; Li L; Zhou P; Zhu Y; Tang H; Huang Y; Li W; Zhang L
PLoS One; 2017; 12(8):e0182168. PubMed ID: 28767733
[TBL] [Abstract] [Full Text] [Related]
[Next]
